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Abstract
Thoroughbred horses have been selected for exceptional racing performance resulting in system-wide structural and
functional adaptations contributing to elite athletic phenotypes. Because selection has been recent and intense in a closed
population that stems from a small number of founder animals Thoroughbreds represent a unique population within which
to identify genomic contributions to exercise-related traits. Employing a population genetics-based hitchhiking mapping
approach we performed a genome scan using 394 autosomal and X chromosome microsatellite loci and identified
positively selected loci in the extreme tail-ends of the empirical distributions for (1) deviations from expected heterozygosity
(Ewens-Watterson test) in Thoroughbred (n=112) and (2) global differentiation among four geographically diverse horse
populations (FST). We found positively selected genomic regions in Thoroughbred enriched for phosphoinositide-mediated
signalling (3.2-fold enrichment; P,0.01), insulin receptor signalling (5.0-fold enrichment; P,0.01) and lipid transport (2.2-
fold enrichment; P,0.05) genes. We found a significant overrepresentation of sarcoglycan complex (11.1-fold enrichment;
P,0.05) and focal adhesion pathway (1.9-fold enrichment; P,0.01) genes highlighting the role for muscle strength and
integrity in the Thoroughbred athletic phenotype. We report for the first time candidate athletic-performance genes within
regions targeted by selection in Thoroughbred horses that are principally responsible for fatty acid oxidation, increased
insulin sensitivity and muscle strength: ACSS1 (acyl-CoA synthetase short-chain family member 1), ACTA1 (actin, alpha 1,
skeletal muscle), ACTN2 (actinin, alpha 2), ADHFE1 (alcohol dehydrogenase, iron containing, 1), MTFR1 (mitochondrial fission
regulator 1), PDK4 (pyruvate dehydrogenase kinase, isozyme 4) and TNC (tenascin C). Understanding the genetic basis for
exercise adaptation will be crucial for the identification of genes within the complex molecular networks underlying obesity
and its consequential pathologies, such as type 2 diabetes. Therefore, we propose Thoroughbred as a novel in vivo large
animal model for understanding molecular protection against metabolic disease.
Citation: Gu J, Orr N, Park SD, Katz LM, Sulimova G, et al. (2009) A Genome Scan for Positive Selection in Thoroughbred Horses. PLoS ONE 4(6): e5767.
doi:10.1371/journal.pone.0005767
Editor: Cecile Fairhead, Pasteur Institute, France
Received November 21, 2008; Accepted January 22, 2009; Published June 2, 2009
Copyright:  2009 Gu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: EWH is supported by a Science Foundation Ireland President of Ireland Young Researcher Award (04/YI1/B539). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Emmeline.Hill@ucd.ie
Introduction
As flight animals and grazers the wild ancestors of modern
horses were naturally selected for speed and the ability to traverse
long distances. Since horses were domesticated on the Eurasian
steppe some 6,000 years ago [1] they have been selected for
strength, speed and endurance-exercise traits. This process has
been uniquely augmented in Thoroughbred horses, which for four
centuries have been subject to intense artificial selection for
system-wide structural and functional adaptations that contribute
to athletic performance phenotypes. As a result Thoroughbreds
possess a range of extreme physiological characteristics enabling
both high anaerobic and aerobic metabolic capabilities. In
comparison to other athletic species of similar size, the aerobic
capacity or maximal oxygen uptake (VO2max) of Thoroughbreds is
superior (.200 ml O2/kg/min) [2,3,4] and is achieved by a
remarkable oxygen carrying capacity and delivery facilitated by
structural and functional adaptations involving the respiratory and
cardiovascular systems [5]. Specifically, some of these adaptations
include a large lung volume, high maximum haemoglobin
concentration and cardiac output as well as a large muscle mass
(approximately 55%) to body weight ratio, high skeletal muscle
mitochondrial density and oxidative enzyme activity and large
intramuscular stores of energy substrates (primarily glycogen) in
which equivalent concentrations are only achieved in human
skeletal muscle after carbohydrate loading [6,7,8,9]. Similar to
humans, the VO2max in horses is usually limited by oxygen supply
to the mitochondria rather than by mitochondrial oxidative
capacity [10], with the respiratory system in horses unable to meet
the metabolic demands of exercising muscle [11,12].
Although the physical and physiological adaptations contribut-
ing to elite athleticism in Thoroughbred are well described, the
genes contributing to an athletic phenotype have not yet been
identified. Domestic animal species provide valuable opportunities
to identify genes underlying phenotypes that have been strongly
selected because discrete breeds have arisen relatively recently
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population is a closed population established in the 16
th and 17
th
centuries from crosses between local Galloway and Irish hobby
horses with imported Eastern stock [13]. As with many
domesticates, the Thoroughbred originates from a small number
of founders; just one founder stallion contributes to 95% of
paternal lineages and ten founder mares account for 72% of
maternal lineages [14]. However, despite a limited number of
founders and strong selection for racetrack performance some
35% of variation in performance is heritable [15,16]. These
population demographics coupled with intense recent selection for
athleticism offer a unique opportunity to identify genomic
contributions to exercise-related traits.
A number of approaches may be taken to identify genes
underlying phenotypic adaptations. Whereas a candidate gene
approach requires a priori knowledge of gene function and linkage
mapping requires information about familial relationships as well
as access to samples from large numbers of relatives, hitchhiking
mapping using population genetics-based approaches evaluates the
effects of natural or artificial selection across whole genomes in
populations of unrelated individuals that have been subjected to
differential selection pressures for the trait or traits of interest
[17,18,19,20]. Although it is generally considered that microsat-
ellites themselves will not be subject to selection, loci closely linked
to the microsatellites will influence their population genetic
behaviour [17,18,19,21,22,23]. Therefore we have employed a
hitchhiking mapping approach to identify signatures of positive
selection in the Thoroughbred genome and to localise genomic
regions containing genes influencing exercise-related phenotypes.
Results
Identification of selected genomic regions
The Ewens-Watterson test statistic identifies positively selected
marker loci by evaluating significant deviation from expected
heterozygosity (Dh/sd) at individual loci in a single population
[24,25]. Loci experiencing the greatest selection pressures can be
found in the extreme tail-ends of empirical distributions [26].
Considering the empirical distribution for Dh/sd (Figure 1) we
identified 18 loci in the tail-ends of the distribution (P,0.01) in
Thoroughbred representing ,5% of all loci. At the negative end
of the distribution 17 loci had Dh/sd,23.5 (P,0.01) and 55 had
Dh/sd,22.0 (P,0.05). Whereas loci lying at the negative end of
the Dh/sd distribution have been subject to positive selection, the
positive end of the distribution indicates the effects of balancing
selection where two or more alleles are maintained at higher
frequency than expected under neutral genetic drift. One of fifteen
loci with Dh/sd.1.5 deviated significantly (P,0.01) from
expectation. Three (COR101, NVHEQ040 and AHT023) of the
selected loci also had significant deviations from neutrality in
Connemara and one locus (AHT023) was monomorphic in Akhal-
Teke.
Studies in other species have shown positively selected genes to
have unusually large differences among populations and therefore
Figure 1. Empirical distribution for Dh/sd. The empirical distribution for Dh/sd scores (horizontal axis) from the Ewens-Watterson test. The
vertical axis indicates the number of loci with the corresponding Dh/sd score. The positions in the distribution of the regions that have been subject
to selection in Thoroughbred are indicated by the gene symbols for the strongest candidate genes. Genes in the negative tail-end of the distribution
may have been subject to positive selection. Genes in the positive end of the distribution may have been subject to balancing selection.
doi:10.1371/journal.pone.0005767.g001
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the distribution for global FST [17,26,27,28,29]. The Ewens-
Watterson test is particularly useful for highly polymorphic loci,
such as microsatellites, because it is a function of the number of
observed alleles. The FST statistic however does not rely on loci to
be highly polymorphic and by evaluating differences among
populations rather than in single populations complements the use
of the Ewens-Watterson test. We therefore used a combined FST
versus Ho approach to identify genomic regions that have been
targets for positive selection in Thoroughbred. Plotting FST versus
Ho at each locus in each population revealed a cluster of outlier
loci with high FST and low Ho unique to Thoroughbred (Figure 2).
The mean global FST was 0.12, much lower than has been
reported for dog breeds where the mean FST calculated from single
nucleotide polymorphism (SNP) data is 0.33 [30]. Over all loci
mean Ho was lowest in Thoroughbred (Ho=0.536); for the other
populations surveyed: Ho=0.587 (Akhal-Teke), Ho=0.630 (Con-
nemara) and Ho=0.672 (Tuva) (Table 1). Another indicator of
population genetic diversity, the mean number of alleles sampled
per locus, was not lowest in Thoroughbred (4.6 SEM60.09) but in
Akhal-Teke (4.0 SEM60.08) and was greatest in Tuva (5.0
SEM60.10). When all populations were considered together the
mean number of alleles per locus was 6.7 SEM60.13. Population
differentiation may arise because of random genetic drift and FST
may be influenced by unequal sample sizes. Therefore, using a less
stringent significance threshold (P,0.05) for the Ewens-Watterson
test we identified nine of the high FST loci that also had a
deficiency in heterozygosity in Thoroughbred. Inter-population
FST and Thoroughbred Ho was plotted across chromosomes
containing the nine most strongly selected loci (Figure 3). Four loci
met the more stringent significance (P,0.01) in the Ewens-
Watterson test. Three loci were common to both tests and one was
just below the threshold (Dh/sd=23.5) for inclusion by the
Ewens-Watterson test (Dh/sd=22.9). The empirical distribution
for FST is shown in Figure 4. Of the highest ranked loci in the
Ewens-Watterson test, two were almost significant (COR008 and
AHT006, P,0.1), two were significant (NVHEQ079 and TKY316,
P,0.05) and one was highly significant (TKY222, P,0.01) for the
FST test.
Functional ontologies in selected regions
Normally, selection does not act on microsatellites per se, but
rather on genes to which they are linked by proximity. Therefore,
the closest flanking loci meeting neutral expectations were used to
define the regions harbouring putative selected genes; although we
expect selected genes to lie closer to the central locus than either
flanking loci. Linkage disequilibrium is expected to decay within
1–2 Mb in Thoroughbred [31], however a strong selective effect
could sweep loci that are located considerably further away. We
interrogated the horse genome sequence (EquCab2.0) for genes in
the highest ranked regions deviating from expected heterozygosity
in Thoroughbred. This analysis included the outlier FST regions
confirmed as selected regions in the Ewens-Watterson test as these
were the best candidates to contain genes under selection in
Thoroughbred. In a list of 765 genes located in the 19 regions we
searched for gene ontology (GO) terms that may be important for
exercise-related athletic phenotypes. GO Biological Processes,
Cellular Compartments and Molecular Functions were returned
for 592 genes using the Homo sapiens GO database [32]. Genes with
functions in 67 GO Biological Processes and 32 GO Molecular
Functions (Table S2) were found significantly more frequently
than expected (P,0.05) for all searched (functionally annotated)
genes (n=15,360). GO terms that may have functional relevance
for selection in Thoroughbred are listed in Table 2.
We refined the complete list of genes in selected regions to a list
of 87 candidate genes (85 had functional annotations on the H.
sapiens GO database) that had the following (select) GO Biological
Processes (containing more than five candidate genes): anatomical
structure development; blood vessel development; carbohydrate
metabolic process; carboxylic acid metabolic process; generation
of precursor metabolites and energy; glucose metabolic process; G-
protein signalling, coupled to IP3 second messenger (phospholi-
pase C activating); insulin receptor signalling pathway; muscle
development; positive regulation of catalytic activity; skeletal
development and transmembrane receptor protein tyrosine kinase
signalling pathway. Six KEGG pathways were among the list of
candidate genes and included fatty acid metabolism, oxidative
phosphorylation and regulation of actin cytoskeleton.
The FST statistic was used to identify genomic regions that
distinguished Thoroughbred from non-Thoroughbred. Because
FST may be influenced by unequal sample sizes, we limited our
search for genes of interest to the nine high FST regions that also
had significant deviations from expected heterozygosity in
Thoroughbred. Gene ontology (GO) terms for Biological Processes
returned 369 genes using the H. sapiens GO database. Genes with
functions in 35 GO Biological Processes and 21 Molecular
Functions (Table S3) were found significantly (P,0.05) more
frequently in this gene list than expected for all searched
(functionally annotated) genes (n=15,360). GO terms that may
have functional relevance for selection in Thoroughbred are listed
in Table 3.
As for the selected regions identified by the Ewens-Watterson
test, the complete gene list was refined to a candidate gene list of
74 genes (72 had functional annotations on the H. sapiens GO
database) that had the following (select) GO Biological Processes
(containing more than five candidate genes): alcohol metabolic
process; blood vessel development; lipid metabolic process; muscle
development; skeletal development; steroid metabolic process; and
transmembrane receptor protein tyrosine kinase signalling path-
way. Twelve genes localised to the mitochondrion of which seven
were specifically localised to the mitochondrial inner membrane.
Three KEGG pathways were found among the list of candidate
genes and included Type II diabetes mellitus.
As well as genes within related categories, the candidate gene
lists contained genes that had no known functional relatives. Genes
acting alone may have a singular strong selective effect and
therefore each candidate was considered individually. A full list of
candidate genes for each selected region is given in Tables 4 and 5.
Biological relevance of candidate genes
The region with the strongest signal for selection based on
population differentiation (FST=0.613, P,0.01) and low Thor-
oughbred heterozygosity was relatively gene-poor containing
annotations for only four genes: ANKH (ankylosis, progressive
homolog [mouse]), DNAH5 (dynein, axonemal, heavy chain 5),
FBXL7 (F-box and leucine-rich repeat protein 7) and TRIO (triple
functional domain [PTPRF interacting]). Considering the mark-
edly lower heterozygosity in Thoroughbred (Ho=0.032) compared
to non-Thoroughbreds (Akhal-Teke Ho=0.677; Connemara
Ho=0.426; Tuva Ho=0.583) we expected to find a gene subject
to a particularly strong selective effect during Thoroughbred
development. The observed low heterozygosity in Thoroughbred
was not a function of the small number of detected alleles (n=2)as
Connemara also had just two alleles. Mutations in dynein genes
(DNA11, DNAH5, and DNAH11) have been linked to a common
cause of male infertility in humans, asthenozoospermia, which is
inherited in a dominant sex-specific manner [33]. Consequently,
DNAH5 may represent a good candidate for selection because of
Genome Scan in Thoroughbred
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departed from expected heterozygosity in the Ewens-Watterson
test, we found significant enrichments for genes in a number of
functional categories relevant to reproduction including gamete
generation, mating, sexual reproduction and spermatogenesis and
genes in these categories may also provide strong candidates for
selection for fertility traits.
The investigation of overrepresented functional ontologies
revealed a significant enrichment for genes with functions in the
phosphoinositide 3-kinase (PI3K) and insulin-signalling pathways
in positively selected genomic regions in Thoroughbred. Insulin
stimulates glucose transport to maintain glucose homeostasis via a
number of transcriptionally active signalling pathways [34].
Among these the PI3K pathway plays a key role in insulin-
stimulated glucose transport in skeletal muscle [35,36,37] via its
interaction with IRS1 (insulin receptor substrate 1) [38] and its
regulation by insulin of PIK3R1 (phosphoinositide-3-kinase,
regulatory subunit 1 [alpha]) gene expression [35]. In type 2
diabetes (T2DM) regulation by insulin of genes via the PI3K
pathway is disrupted [39]. Among selected regions in Thorough-
bred we found PIC3C3 (phosphoinositide 3-kinase, class 3), IRS1
and PIK3R1, transcripts of which are dysregulated in skeletal
muscle from T2DM patients following stimulation with insulin
[38,40]. The insulin-receptor signalling pathway genes FOXO1A
(forkhead box O1A), GRB2 (growth factor receptor-bound protein
2), PTPN1 (protein tyrosine phosphatase, non-receptor type 1),
SOCS3 (suppressor of cytokine signalling 3), SOCS7 (suppressor of
cytokine signalling 7) and STXBP4 (syntaxin-binding protein 4)
were also found in positively selected regions. The suppressor of
cytokine signalling (SOCS) proteins have been implicated in the
inhibition of insulin signalling by a number of mechanisms
including inhibition of IRS [41]. As well as IRS1, genes in the
T2DM KEGG pathway in selected regions included CACNA1G
(calcium channel, voltage-dependent, T type, alpha 1G subunit)
and CACNA1E (calcium channel, voltage-dependent, R type, alpha
1E subunit) within which polymorphisms have been linked with
T2DM [42].
At the tail-end of the distribution for deviation from expected
heterozygosity in the Ewens-Watterson test we found an extreme
outlier microsatellite locus (COR008, Figure 1). Two candidate
genes, ADHFE1 (alcohol dehydrogenase, iron containing, 1) and
MTFR1 (mitochondrial fission regulator 1), were identified among
16 genes in this 3.4 Mb region. MTFR1 encodes an inner
mitochondrial membrane protein, previously known as CHPPR
(chondrocyte protein with a poly-proline region), that promotes
mitochondrial fission [43]. The expression of MTFR1 in mice is
highest in testes where it functions to combat oxidative stress [44].
Mitochondrial function and the management of reactive oxygen
species are important for favourable exercise responses and
therefore MTFR1 may impose strong selection pressure in
Thoroughbred by protection of mitochondria-rich tissue against
oxidative stress.
The ADHFE1 gene encodes hydroxyacid-oxoacid transhydro-
genase [45], the enzyme responsible for the oxidation of 4-
hydroxybutyrate (gamma-hydoxybutyrate, GHB), an energy
regulator that promotes the release of growth hormone [46]
during periods of sleep [47]. GHB has been used illegally as a
performance enhancing drug by human athletes [48,49]. The
expression pattern and function of ADHFE1 in adiposity may be
relevant to its selection for exercise performance. In obese adipose
tissue and following treatment of 3T3-L1 adipocytes in vitro with a
PI3K inhibitor, LY294002 [50], ADHFE1 transcripts are dysreg-
ulated [51]. ADHFE1 is preferentially expressed in highly
metabolic tissues and transcript expression is highest in brown
adipose tissue [51]. The fate determination of common brown fat
and muscle precursor cells into brown adipose tissue is controlled
by the BMP7 (bone morphogenic protein 7) [52] and PRDM16
(PRD-1-BF1-RIZ1 homologous domain containing 16) genes [53].
Although we did not find evidence for selection adjacent to the
PRDM16 gene region (the closest microsatellite loci were located
7.4 Mb and 23.8 Mb either side), we found BMP7 among selected
regions in Thoroughbred. This locus had no evidence for selection
in non-Thoroughbreds. This region corresponds to human
20q13.2–13.3, a well described obesity quantitative trait locus in
mouse [54]. A number of receptor (ACVR1B, ACVR2,), signalling
(SMAD8) and downstream target genes (COX7B2) of BMP7 were
also among the selected regions. The bone morphogenic proteins
(BMPs) signal via binding to a heteromeric receptor complex
comprised of three type I and three type II transmembrane serine/
threonine kinases [55] including ACVR2A (activin A receptor, type
IIA). The receptor complex activates SMAD (mothers against
decapentaplegic Drosophila homologue) pathway proteins that
along with the p38 MAP kinase pathway are responsible for most
of the functionalities of BMPs [56]. In the single outlier region at
the positive end of the distribution for expected heterozygosity was
COX7B2 (cytochrome c oxidase subunit VIIb2) an isoform of the
BMP7 target gene COX7A1 (cytochrome c oxidase subunit VIIa
polypeptide 1 [muscle]) [52]. In human populations BMPs and
Figure 2. FST versus heterozygosity. FST (vertical axis) versus heterozygosity (horizontal axis) plots for Thoroughbred, Akhal-Teke, Connemara and
Tuva at 394 genome-wide microsatellite loci.
doi:10.1371/journal.pone.0005767.g002
Table 1. Population genetic diversity.
Population Geographic origin nH o
Ave. no. alleles
sampled/locus SEM
Thoroughbred United Kingdom and Ireland 112 0.536 4.6 0.092
Akhal-Teke Turkmenistan 18 0.587 4.0 0.077
Connemara Ireland 17 0.630 4.5 0.086
Tuva Republic of Tuva 17 0.672 5.0 0.099
Horse population origins, number of individuals genotyped (n), average observed heterozygosity (Ho), mean number of alleles sampled per locus and standard error of
mean (SEM).
doi:10.1371/journal.pone.0005767.t001
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have strong selection signatures [57]. The retinoblastoma protein,
encoded by the retinoblastoma gene (RB1) has also been reported
to be responsible for the control of adipocyte differentiation into
white or brown fat tissue [58] and RB1 was also among the genes
found in the selected regions.
We detected one region that deviated very significantly from
neutral expectations for both the FST and Ewens-Watterson tests
that contained genes of particular importance, including PDK4.
The expression of PDK4 is co-ordinated by the transcriptional co-
activator PGC-1a via ERRa (estrogen-related receptor alpha)
binding [59]. PGC-1a, encoded by the PPARGC1A (peroxisome
proliferator-activated receptor gamma, coactivator 1 alpha) gene,
is a key regulator of energy metabolism that regulates insulin
sensitivity by controlling glucose transport via SLC2A4 (solute
carrier family 2 (facilitated glucose transporter), member 4;
previously GLUT4), drives the formation of oxidative muscle
fibres and co-ordinates mitochondrial biogenesis via its interaction
with nuclear encoded mitochondrial protein genes [60].
The regulation of glucose utilisation is tightly controlled by the
uptake of glucose by glucose transporters, the rate of glycolytic flux
and the conversion of pyruvate to acetyl-CoA in mitochondria via
the catalytic function of the pyruvate dehydrogenase complex
(PDC). The critical rate limiting step in the oxidation of glucose is
the regulation of assembly of the PDC which is controlled by
pyruvate dehydrogenase kinase (PDK). PDK blocks the formation
of the PDC resulting in the beta-oxidation of fatty acids to acetyl-
CoA as the substrate for oxidative phosphorylation. Three genes
(PDK2, PDK3 and PDK4) of the four genes that encode PDK
isoforms are located in the positively selected regions in
Thoroughbred. Also, the PDK4 gene promoter contains a binding
site for the FOXO1A transcription factor, a key regulator of insulin
signalling in liver and adipose tissue. Single nucleotide polymor-
phisms in FOXO1A have been found to have a protective effect on
T2DM development and related phenotypes in humans [61].
FOXO1A was also found among the positively selected genomic
regions in Thoroughbred and its PDK4 promoter binding site
sequence is conserved in horse. The transcription factors FOXO1
and SMAD have also been shown to be responsible for myostatin
gene regulation and therefore play key roles in the regulation of
muscle growth [62].
Hypoxia is an important stimulus for exercise-induced func-
tional changes in skeletal muscle enhancing oxygen delivery and
utilisation [63] by the activation of downstream genes of the
Figure 3. Chromosome-wide FST versus Thoroughbred heterozygosity. FST (solid line) versus Thoroughbred heterozygosity (dashed line)
plots across chromosomes for the nine highest FST regions with significant (P,0.05) deviations from expected heterozygosity (Dh/sd) in
Thoroughbred. Loci defining selected genomic regions are highlighted. Left vertical axis: FST; Right vertical axis: Thoroughbred heterozygosity;
Horizontal axis: chromosome position (Mb).
doi:10.1371/journal.pone.0005767.g003
Figure 4. Empirical distribution for FST. The empirical distribution for global differentiation, FST (horizontal axis). The vertical axis indicates the
number of loci with the corresponding FST. The positions of the regions that have been subject to positive selection in Thoroughbred are located in
the tail-end of the distribution and are indicated by the gene symbols for the strongest candidate genes.
doi:10.1371/journal.pone.0005767.g004
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factor-1 alpha) [64]. In humans, sequence variation in HIF1A has
been associated with VO2max [65]. Angiopoiesis is one of the many
adaptations effected by HIF-1a signalling [66,67]. Three genes
with roles in angiogenesis, ANGPT2 (angiopoietin 2), ANGPTL1
(angiopoietin-like 1) and VEGFC (vascular endothelial growth
factor C) were among genes in the selected regions. Also,
ANGPTL3 (angiopoietin-like 3) was in the region defined by
AHT107 that was just outside the cut-off FST=0.3, but was
significant (FST=0.279, P,0.05). The gene encoding HIF-1a
(HIF1A) is located 7.2 Mb from the nearest microsatellite locus
(UM012) at the proximal end of ECA24. Although UM012 was
marginally outside the highest ranked regions (Dh/sd=22.9,
P,0.05) in the Ewens-Watterson test it did have a significant
(P,0.05) reduction in heterozygosity and also had a higher FST
(FST=0.215, P=0.10) than six of the nine FST regions that had
very significant (P,0.01) Dh/sd scores. Therefore, the genomic
region containing HIF1A can be considered to have a moderate
signature of positive selection. Another adaptation mediated by
HIF-1a is the induction of glycolytic flux although we found no
evidence for a significant abundance of glycolytic genes among the
positively selected regions and no strong candidates were identified
in this functional category. On the other hand, HIF-1a and PCG-
1a have both been reported to induce COX4 (cytochrome c
oxidase subunit 4) protein in human skeletal muscle [68,69,70].
Cytochrome c oxidase (COX) is a multi-subunit enzyme
(Complex IV) that catalyzes the electron transfer from reduced
cytochrome c to oxygen in mitochondrial respiration. Mitochon-
drial function is dependent on the proper assembly of electron
transport chain complexes. Nuclear encoded COX4 is responsible
for the regulation and assembly of mitochondrially encoded
subunits of Complex IV on the inner mitochondrial membrane
[69]. COX4I1 was found among the positively selected regions in
Thoroughbred along with nine other genes with roles in the
KEGG oxidative phosphorylation pathway. In human skeletal
muscle, COX4 mRNA levels have been shown to be associated
with mitochondrial volume and, by extension, VO2max [71].
The most important role of mitochondria is the generation of
ATP accomplished by the oxidative phosphorylation of acetyl-
CoA arising either from glycolysis or fatty acid oxidation. We
found one locus (COR001) that appeared to be fixed in
Thoroughbred while retaining diversity in non-Thoroughbred
populations; three alleles were sampled in Connemara. Notably,
heterozygosity was also markedly low in Akhal-Teke. The region
defined by this locus contained 49 genes, but only one good
candidate for selection, the gene encoding acyl-CoA sythetase
(ACSS1, acyl-CoA synthetase short-chain family member 1). Acyl-
CoA synthetase has been suggested as a key control factor in the
oxidation of fatty acids [72]. We also found a significant
enrichment for genes with specific functions in fatty-acid
metabolism and lipid transport among positively selected regions.
Since muscle plays a key role in Thoroughbred performance
and may be particularly important to distinguish Thoroughbred
[73,74], we searched all high FST regions for genes with GO
Biological Processes relevant to muscle structure and function
including: adult somatic muscle development, muscle cell
Table 2. Overrepresented gene ontologies (Dh/sd).
GO Biological Process GO Identifier Number of genes P Fold enrichment
Phosphoinositide-mediated signalling GO:0048015 13 0.000 3.2
Insulin receptor signalling pathway GO:0008286 7 0.002 5.0
G-protein signalling, coupled to IP3 second messenger
(phospholipase C activating)
GO:0007200 10 0.003 3.4
Spermatogenesis GO:0007283 18 0.005 2.1
Skeletal development GO:0001501 18 0.007 2.0
Porphyrin biosynthetic process GO:0006779 4 0.035 5.5
Peptidyl-histidine phosphorylation GO:0018106 3 0.035 9.7
Response to hydrogen peroxide GO:0042542 4 0.039 5.2
Lipid transport GO:0006869 9 0.049 2.2
Muscle development GO:0007517 12 ,0.1 1.8
Response to reactive oxygen species GO:0000302 4 ,0.1 3.8
Cellular lipid metabolic process GO:0044255 32 ,0.1 1.3
GO Cellular Component
Mitochondrion GO:0005739 56 0 1.5
Sarcoglycan complex GO:0016012 3 0.027 11.1
GO Molecular Function
Diacylglycerol kinase activity GO:0004143 5 0 9.1
Pyruvate dehydrogenase (acetyl-transferring) kinase activity GO:0004740 3 0.008 20.4
Oxidoreductase activity, acting on peroxide as acceptor GO:0016684 5 ,0.1 3.2
Electron donor activity GO:0009053 2 ,0.1 27.3
Phospholipid transporter activity GO:0005548 4 ,0.1 3.8
Gene ontology biological processes, cellular components and molecular functions that were significantly overrepresented among genes within selected regions and
may be relevant to Thoroughbred selection. The complete list is given in Table S2. Selected regions were defined by deviation from expected heterozygosity (Ewen-
Watterson test) in Thoroughbred and included the four high FST regions that had highly significant (P,0.01) reductions in Thoroughbred heterozygosity. The table
shows the number of genes in each functional group, P-value for significance of over-representation and fold-enrichment.
doi:10.1371/journal.pone.0005767.t002
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fibre development, muscle system process, myoblast differentia-
tion, negative regulation of muscle development, regulation of
muscle contraction, regulation of muscle development, skeletal
muscle development, skeletal muscle fibre development, smooth
muscle, smooth muscle contraction, somatic muscle development,
striated muscle development and structural constituent of muscle.
Among the 20 muscle-related genes identified were ACTA1
(actin, alpha 1, skeletal muscle) and ACTN2 (actinin, alpha 2) that
are located 2.8 Mb and 3.6 Mb respectively from TKY015 that
defined the region with the second highest inter-population
differentiation (FST=0.452, P,0.01) and comparatively low
diversity in Thoroughbred (Ho=0.274). Alpha actin protein is
found principally in muscle and is a major constituent and
regulator of the contractile apparatus [75,76]. Mutations in
ACTA1 have been found to disrupt sarcomere function in patients
with congenital fibre type disproportion [77] and other muscle
weakness pathologies [78]. In skeletal muscle a-actinin is
responsible for cross linking actin filaments between adjacent
sarcomeres and is known to interact with PI3K [79]. Polymor-
phisms in the gene encoding a-actinin 3 (ACTN3) are among the
best characterised athletic-performance associated variants in
human endurance athletes [80,81,82] and evidence for positive
selection in the genomic region surrounding ACTN3 has been
reported in humans [83]. While ACTN3 is expressed principally in
fast muscle fibres ACTN2 is more widely expressed in skeletal and
cardiac muscle. ACTN2 is structurally and functionally similar to
ACTN3 and it has been suggested that ACTN2 compensates
function in the absence ACTN3 [84]. Interactions between actin
(and tubulin) and the cytosolic chaperonin CCT [85,86] have been
described suggesting co-evolution to facilitate protein folding [87].
PCYT1B (phosphate cytidylyltransferase 1, choline, beta), the gene
encoding CCT-beta, was 600 kb from LEX026 that defined a
2.9 Mb region that had a significant reduction in expected
heterozygosity in Thoroughbred (Dh/sd=23.89, P,0.01).
Finally, among the muscle-related genes in the high FST regions
we found three (SGCA, SGCE and SGCZ) that encode transmem-
brane protein members (a, b, c, d, e, and f) of the sarcoglycan
complex [88]. A fourth sarcoglycan gene (SGCB) was found in the
single region (LEX007) with evidence for balancing selection in the
Ewens-Watterson test. The sarcoglycan complex is found
associated with the dystophin-glycoprotein complex located at
the sarcolemma of cardiac and skeletal muscle cells linking the
contractile apparatus of the muscle with the lamina [89] thus
providing a mechano-signalling role. Mutations in any one of the
sarcoglycan genes destabilises the entire sarcoglycan complex [88].
Loss of sarcoglycan function leads to progressive loss of skeletal
myofibres or cardiomyocytes such as that seen in patients with
Table 3. Overrepresented gene ontologies (FST).
GO Biological Process GO Identifier Number of genes P Fold enrichment
Spermatogenesis GO:0007283 13 0.007 2.5
Cellular calcium ion homeostasis GO:0006874 9 0.008 3.1
Porphyrin biosynthetic process GO:0006779 4 0.009 8.8
Sexual reproduction GO:0019953 16 0.001 2.0
Skeletal development GO:0001501 12 0.022 2.1
Anatomical structure formation GO:0048646 10 0.029 2.3
Hydrogen peroxide catabolic process GO:0042744 3 0.032 10.4
Regulation of osteoblast differentiation GO:0045667 3 0.037 9.6
Hydrogen peroxide metabolic process GO:0042743 3 0.043 8.9
Mating GO:0007618 3 0.043 8.9
Regulation of catalytic activity GO:0050790 19 0.047 1.6
Insulin receptor signaling pathway GO:0008286 4 ,0.01 4.6
Muscle development GO:0007517 9 ,0.01 2.1
Response to oxidative stress GO:0006979 6 ,0.01 2.6
Actin filament organization GO:0007015 4 ,0.01 3.9
Detection of temperature stimulus GO:0016048 2 ,0.01 20.8
GO Cellular Component
Mitochondrion GO:0005739 34 0.025 1.5
Cortical actin cytoskeleton GO:0030864 3 ,0.01 6.7
GO Molecular Function
G-protein-coupled receptor binding GO:0001664 7 0.008 4.0
Oxidoreductase activity, acting on peroxide as acceptor GO:0016684 5 0.014 5.3
Pyruvate dehydrogenase (acetyl-transferring) kinase activity GO:0004740 2 ,0.01 22.3
KEGG Pathway
Focal adhesion hsa04510 10 ,0.01 1.8
Gene ontology biological processes, cellular components, molecular functions and KEGG pathways that were significantly over-represented among genes within
selected regions and may be relevant to Thoroughbred selection. The complete list is given in Table S3. Selected regions were defined by the nine high FST regions that
had significant (P,0.05) reductions in Thoroughbred heterozygosity. The table shows the number of genes in each functional group, P-value for significance of over-
representation and fold-enrichment.
doi:10.1371/journal.pone.0005767.t003
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Mutations in SGCE cause myoclonus-dystonia syndrome [91]
and penetrance is influenced by paternal expression of the gene
[92,93], while defects in SGCA cause limb girdle muscular
dystrophy [94]. The dystrophin-glycoprotein complex contributes
to the integrity and stability of skeletal muscle by its association
with laminin receptors and the integrin-associated complex in the
costamere [89]. Focal adhesion complexes form part of the
costamere [for review see: 95]. Among the positively selected
regions determined by high FST we found a significant enrichment
for genes in the KEGG focal adhesion pathway. These genes
included TNC (tenascin C), TNN (tenascin N), TNR (tenascin R),
LAMC2 (laminin, gamma 2), COL1A2 (collagen, type1, alpha 2),
COL4A4 (collagen, type 4, alpha 4) and ITGA3 (integrin alpha 3).
TNC (tenascin C) may be particularly important for muscle
integrity because of its role in the protection against mechanically-
induced damage [96].
Discussion
Intense artificial selection for racetrack performance has
resulted in an exercise-adapted phenotype leaving signatures in
the Thoroughbred genome that we have revealed using population
genetic methods. Genes for exercise-related physiology as well as
sexual reproduction seem to have been subject to the strongest
selection pressures. We have identified a number of candidate
performance genes that may contain variants that could
distinguish elite racehorses from members of the population with
less genetic potential for success. Revealing such polymorphisms
may aid in the early selection of young Thoroughbreds in the
multi-billion dollar global Thoroughbred industry.
The presence of genes for a-actinin, a-actin and its chaperon,
CCT, and four of the six sarcoglycan complex genes as well as an
overrepresentation of focal adhesion complex genes in positively
selected regions in Thoroughbred suggest that selection for muscle
strength phenotypes has played a major role in shaping the
Thoroughbred. A better understanding of the role that these genes
play in the strength and integrity of muscle may contribute to
improved knowledge of mechanical sensing and load transmission
[97] and may impact treatment of musculoskeletal disorders in
humans.
Understanding genes selected for exercise-related phenotypes
has potential to impact human medicine in other areas. One of the
most notable findings was that positively selected genomic regions
in Thoroughbred horses are enriched for insulin-signalling and
lipid metabolism genes. There is a growing concern about the
rapidly increasing incidence of obesity and its pathological
consequences in the development of type 2 diabetes (T2DM)
among human populations in the developed world [98]. Insulin is
responsible for glucose homeostasis and insulin-resistance is a key
feature of T2DM [99]. In obese individuals, skeletal muscle
oxidative capacity and responsiveness to insulin are impaired
[100]. Therefore, identifying and understanding the molecular
functions of genes responsible for the control of fat metabolism and
insulin sensitivity holds great promise for the development of
pharmaceutical interventions for obesity and diabetes related
health problems. In humans, exercise training is a common
intervention to combat obesity [101] because physical exercise
stimulates skeletal muscle insulin activity and glucose transport
and the utilisation of free fatty acids as an energy substrate while
promoting oxidative capacity by increasing mitochondrial mass
and enhancing the development of oxidative muscle fibres [102].
Equine metabolicsyndrome (EMS) is a recently described clinical
disease in which horses develop insulin insensitivity similar to that
described for T2DM in humans [103,104,105]. In the same way,
management of EMS in horses requires a combination of exercise
and dietary modification towards a reduction in calories and a
substitution of carbohydrates with fat [104,105,106,107]. During
exercise, the rate of ATP generated to power muscle contraction is
determined by the metabolic fuel available (carbohydrate and fat)
which is either stored in the muscle (glycogen, triglycerides) or taken
from the circulation (fatty acids, glucose) [108]. Certainly, the
intensity and duration of exercise as well as diet will dictate the
relative contribution of the different substrates to fuel metabolism.
In horses, energy for low-intensity exercise is predominantly
obtained from fat whereas energy for high-intensity exercise has a
greater reliance on muscle glycogen [109,110]. Although equine
diets are typically high in carbohydrates and low in lipids, it has
been found that chronic adaptation to fat-fortified feeds confers
benefits to athletic performances of horses that may be due to
enhanced insulin sensitivity and fat utilisation [103]. It has further
been proposed that fat-enhanced diets may also sustain or enhance
other signalling functions of insulin receptors on glycolysis and lipid
utilization [111]. This possibility was supported by studies that
found that the lactate thresholdaswell as thepeaklactate(indicative
of glycolytic activity) increased in Arabian horses adapted to a fat-
enhanced rather than a sugar-enhanced diet [112]. Fat-adapted
horses have been found to have faster times on the track [113] as
well as longer run times to fatigue and higher peak plasma lactate
concentrations [114].
Brown adipose tissue is distinct from white adipose tissue in its
ability to expend energy and generate heat rather than as a lipid
storage unit [115]. Until recently it was thought that brown
adipose tissue occurred only in mammalian infants (and in rodent
adults) but it is now thought that the metabolically active
mitochondria-rich tissue may be retained in adults [116] and
derives from a common precursor cell for muscle [52,53]. The
incidence of brown adipose tissue in young horses and its
persistence in adult horses, to our knowledge, have not been
reported. Positive selection for genomic regions containing genes
such as ADHFE1 that preferentially functions in highly metabolic
tissues including brown adipose tissue, as well as two of the key
determinants of brown fat cell fate, BMP7 and RB1, and their
receptors and signalling molecules, raises the intriguing question of
whether Thoroughbred skeletal muscle retains brown fat-like
properties, thus providing a selective advantage. The retention of
brown fat into adulthood has been suggested as a mechanism to
combat obesity [52,53] and experimental increases in brown
adipose tissue in rodents has been associated with a lean healthy
phenotype [117].
The oxidation of fatty acids is highly efficient in the generation
of ATP and is controlled by the expression of PDK4 in skeletal
muscle during and after exercise [118]. Equine PDK4 is located in
the genomic region that had the highest inter-population
differentiation as well as a highly significant deviation from
neutrality in the Ewens-Watterson test and is therefore one of the
strongest candidates for selection for exercise adaptation. The
location of the ADHFE1 and ACSS1 genes in two of the strongest
selected regions as well as a 2.2-fold overrepresentation of lipid
transport genes and an abundance of genes with specific lipid
metabolism function among positively selected genomic regions
suggests that Thoroughbreds have been selected for aerobic
energy production increasing flux through fatty acid oxidation and
electron transport. High concentrations of circulating fatty acids
have a disruptive effect on insulin signalling pathways causing
insulin resistance and the manifestation of T2DM in humans
[119]. It has been reported that Thoroughbreds have an enhanced
delivery of fat and glucose into skeletal muscle [103] and
Genome Scan in Thoroughbred
PLoS ONE | www.plosone.org 12 June 2009 | Volume 4 | Issue 6 | e5767accumulate less fat than other horse breeds when fed the same diet
[73,120], which together may contribute to the naturally lean
athletic phenotype for which they are renowned. The presence of
genes that suggest a preference for the oxidation of fatty acids for
energy production as well as insulin-mediated molecular signalling
genes in the key selected genomic regions in a population that has
been strongly selected for exquisite adaptations to exercise strongly
supports the role of exercise in the prevention of obesity and the
protection against T2DM. While rodent models for obesity and
diabetes are well established [121,122], here we propose
Thoroughbred as a novel in vivo large animal model that may
contribute to further insights into the complex molecular
interactions that serve to protect against obesity and related
pathological phenotypes that are influenced by exercise.
Materials and Methods
Horse Populations
Thoroughbred. A Thoroughbred is a registered racehorse
that can trace its ancestry to one of three foundation stallions (The
Darley Arabian, The Godolphin Arabian and The Byerley Turk) and one
of the approximately 30 foundation mares entered in The General
Studbook [123]. One hundred and twelve Thoroughbred horse
samples were chosen from a repository (n=815) collected with
informed owners’ consent from breeding, training and sales
establishments in Ireland, Britain and New Zealand during 1997–
2006. In all cases pedigree information was used to control for
genetic background by exclusion of samples sharing relatives
within two generations. Also, overrepresentation of popular sires
within the pedigrees was avoided where possible. This work has
been approved by the University College Dublin Animal Research
Ethics Committee.
Non-Thoroughbreds. Fifty-two non-Thoroughbred samples
were selected from two likely founder populations for the
Thoroughbred: Akhal-Teke (n=18), Connemara Pony (n=17);
and an ancient horse population, Tuva (n=17). Akhal-Teke horses
have been kept by Turkomen peoples in the geographic regions in
and surrounding Turkmenistan for centuries and they may have
contributed to the Thoroughbred through imported Eastern
stallions (For example, The Byerley Turk). The Connemara Pony
is an indigenous Irish horse population and was chosen to
represent ancestral local horses of Ireland and Britain as Galloway
and Irish hobby horses no longer exist. Tuva horses are an ancient
horse population originating in the Republic of Tuva,
geographically located in the southern Siberian steppe, one of
the accepted centres of horse domestication [1].
DNA preparation
Genomic DNA was extracted from either fresh whole blood or
hair samples. Blood samples were collected in 7 ml Vacutainer
K3EDTA blood collection tubes (Becton Dickinson, Franklin
Lakes, NJ). Hair samples with visible hair roots were collected in
airtight zip-lock bags. DNA was extracted using a modified version
of a standard phenol/chloroform method [124]. DNA concentra-
tions for all samples were estimated using a NanoDrop ND-1000
UV-Vis Spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE).
Microsatellite markers
A panel of 394 equine microsatellites was genotyped; these loci
were selected from the most recent horse genetic maps
[125,126,127] to include markers, as far as possible, equally
distributed across the 31 autosomes (ECA1-31) and the X
chromosome (ECAX) with no a priori knowledge of neighbouring
genes. The physical chromosome positions of the markers were
localized by performing electronic PCR (ePCR) [128] using in silico
primer pairs (Table S1) on the Equus caballus Version 2.0.
(EquCab2.0) genome sequence (www.broad.mit.edu/mammals/
horse/). Considering non-continuity among chromosomes there
were 363 gaps between loci. Almost 85% of the gaps were ,1M b
with an average locus density of one every 5.7 Mb. The median
distance between loci was 4.1 Mb. In the case of dog breeds,
Pollinger et al. [17] suggest when loci are highly polymorphic then
even a moderately distributed (one locus every 0.8 cM) set of loci is
powerful to detect selected regions while minimising Type 1 error.
Microsatellite genotyping
All polymerase chain reactions (PCR) were performed with an
annealing temperature of 57uCi na1 3ml reaction with 50 ng
DNA, 106PCR buffer (Bioline USA, Randolph, MA), 150 mM
each dNTP (Roche, UK), 0.5 U one of four fluorescent labelled
tags (Dye Set DS-31 which contain blue dye 6-FAM, green dye
VIC, yellow dye NED and red dye ROX labelled at the 59 end
with either forward or reverse primer) (Applied Biosystems, Foster
City, CA), 1 U Immolase heat-activated thermostable DNA
polymerase (Bioline USA, Randolph, MA), 0.1 mM forward
primer and 0.25 mM reverse primer (Invitrogen, Carlsbad, CA)
and 2.0 mM MgCl2 (Invitrogen, Carlsbad, CA). All PCR reactions
were performed using the MJ Research DNA EngineH DyadH
thermal-cycler (MJ Research, Bio-Rad Laboratories, Waltham,
MA) and involved initial denaturation at 94uC for 3 min, followed
by 36 cycles of 30 s each at 94uC, 57uC and 72uC and final
extension 10 min at 72uC. Aliquots of 1 ml PCR products
amplified with four different colour dye labelled primers and
three different product sizes were pooled together to reduce cost
and increase efficiency. A total of 12 multiplexed PCR products
were separated in one well by capillary electrophoresis using the
ABI Prism 3700 fragment analyser (Applied Biosystems, Foster
City, CA). Raw genotype data were analyzed using GeneScan
software (Applied Biosystems, Foster City, CA) and alleles were
then scored manually with each allele being assigned an integer
value.
Population genetic analyses
Knowledge of genetic variation under neutral expectations
allows the identification of selection by assessing patterns that
depart from those observed under conditions of neutrality [26].
Whereas population demographic effects will influence the entire
genome, the key to this approach is that only a fraction of the
genome will be subject to selection, and this can be detected as
deviations from allele frequency expectations assuming neutrality.
A number of statistical approaches can be applied to identify
genomic regions that differ significantly from the remainder of the
genome. Selection of advantageous allelic variants in certain
populations can rapidly influence the frequency of alleles in a
population, leading to differential allele frequency spectra at loci
involved in the trait under selection, or loci linked by proximity to
the selected variant [129,130]. Inter-population differentiation
resulting from allele frequency differences has traditionally been
detected using the FST statistic [131,132]. The spread of a
beneficial variant also acts to reduce variability at a locus and its
flanking regions, and this can be evaluated by assessing deviations
from expected heterozygosity.
Inter-population differentiation, global FST [131], allele fre-
quency, average observed heterozygosity (Ho) and the number of
alleles sampled per locus were calculated using the software
program FSTAT version 2.9.3 [133]. Statistical significance for
each observed FST (P value) was calculated as the proportion of
Genome Scan in Thoroughbred
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equal to the observed FST for that locus. For analyses of X
chromosome loci, only female samples were included (Thorough-
bred n=72; Akhal-Teke n=12; Connemara n=17; Tuva n=8).
To evaluate significant departures from expected heterozygosity,
an indicator of positive selection, we calculated the Ewens-Watterson
test statistic (Dh/sd) according to the Ewens formula [25,134] for
each locus in each population using the program BOTTLENECK
[135]. The expected gene diversity (equivalent to Hardy-Weinberg
expected heterozygosity) is calculated as a function of the observed
number of alleles at a locus and the sample size and the difference
between observed and expected heterozygosities is given as Dh. To
normalise differences among microsatellite loci the Dh value is
divided by the standard deviation (sd) of the gene diversity to give a
Dh/sd value. Statistical significance (P) was assigned to Dh/sd values
by completing 1,000 replicate simulations per locus and assuming a
stepwise mutation model.
Gene mining and functional annotation
Genomic regions, delimited by loci flanking each selected locus
(Tables 4 and 5), were interrogated for genes annotated to the
EquCab2.0 genome using the BioMart function in the Ensembl
Genome Browser (www.ensembl.org).
Functional annotations (GO Biological Process, GO Cellular
Component, GO Molecular Function and KEGG Pathway) were
assigned for genes using the functional annotation tool, DAVID 2.0
[136]. Genes were clustered according to functional annotation
using the Functional Annotation Chart command in DAVID 2.0.
Supporting Information
Table S1 Equine microsatellite panel. Locus name and
chromosome location for 394 equine microsatellite loci. The
order on each chromosome is indicated and primer sequences
given.
Found at: doi:10.1371/journal.pone.0005767.s001 (0.08 MB
XLS)
Table S2 Full list of gene ontologies overrepresented in selected
regions (1). The on-line functional annotation bioinformatics tool
DAVID (david.abcc.ncifcrf.gov) was used to search for gene ontology
(GO) terms that were overrepresented among genes in selected
regions. Selected regions were defined by deviation from expected
heterozygosity (Ewen-Watterson test) in Thoroughbred and included
the four high FST regions that had highly significant (P,0.01)
reductions in Thoroughbred heterozygosity. The table shows the GO
category (BP: Biological process; MF: Molecular function; CC:
Cellular compartment; and KEGG pathway), GO functional term
(Term),number of genes in eachGO category (Count),proportion of
the total number of genes in list in that GO category (%), significance
of over-representation (P-value), the names of genes within each GO
category (Genes), the total number of genes in the selected regions list
(List total), the number of genes with GO term in the database (Pop
hits),the total number of genes in the database (Pop total)and the fold
enrichment (Fold change).
Found at: doi:10.1371/journal.pone.0005767.s002 (0.13 MB
XLS)
Table S3 Full list of gene ontologies overrepresented in selected
regions (2). The on-line functional annotation bioinformatics tool
DAVID (david.abcc.ncifcrf.gov) was used to search for gene
ontology (GO) terms that were overrepresented among genes in
selected regions. Selected regions were defined by the nine high
FST regions that had significant (P,0.05) reductions in Thor-
oughbred heterozygosity. The table shows the GO category (BP:
Biological process; MF: Molecular function; CC: Cellular
compartment; and KEGG pathway), GO functional term (Term),
number of genes in each GO category (Count), proportion of the
total number of genes in list in that GO category (%), significance
of over-representation (P-value), the names of genes within each
GO category (Genes), the total number of genes in the selected
regions list (List total), the number of genes with GO term in the
database (Pop hits), the total number of genes in the database (Pop
total) and the fold enrichment (Fold change).
Found at: doi:10.1371/journal.pone.0005767.s003 (0.08 MB
XLS)
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